We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
-2.76%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$5.27B
AUM Growth
+$804M
(+18%)
Cap. Flow
+$1.19B
Cap. Flow
% of AUM
22.6%
Top 10 Holdings %
Top 10 Hldgs %
6.53%
Holding
2,150
New
668
Increased
458
Reduced
360
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$49.8M |
| 2 |
DoorDash
DASH
|
+$40.6M |
| 3 |
Eli Lilly
LLY
|
+$33.4M |
| 4 |
Capital One
COF
|
+$33.1M |
| 5 |
Emerson Electric
EMR
|
+$31.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$116M |
| 2 |
Broadcom
AVGO
|
+$111M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$32.8M |
| 4 |
Rivian
RIVN
|
+$27.2M |
| 5 |
Petrobras
PBR
|
+$25.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.13% |
| 2 | Financials | 14.83% |
| 3 | Industrials | 13.9% |
| 4 | Healthcare | 11.78% |
| 5 | Consumer Discretionary | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
RingCentral
RNG
$4.5B
| $579K | 0.01% |
15,573
-37,626
| -71% | -$1.21M |
|
1227
Castle Biosciences
CSTL
$741M
| $577K | 0.01% |
23,501
+10,255
| +77% | +$336K |
|
1228
Hafnia
HAFN
$3.73B
| $571K | 0.01% |
75,181
-107,037
| -59% | -$710K |
|
1229
Acadia Pharmaceuticals
ACAD
$4.35B
| $571K | 0.01% |
+25,664
| New | +$613K |
|
1230
International Flavors & Fragrances
IFF
$19.5B
| $567K | 0.01% |
7,814
+4,559
| +140% | +$335K |
|
1231
AZZ Inc
AZZ
$4.47B
| $564K | 0.01% |
+4,510
| New | +$569K |
|
1232
Bausch Health
BHC
$1.67B
| $564K | 0.01% |
104,425
-107,806
| -51% | -$645K |
|
1233
Five Below
FIVE
$11.5B
| $563K | 0.01% |
2,465
-15,868
| -87% | -$3.32M |
|
1234
Mesa Laboratories
MLAB
$540M
| $558K | 0.01% |
+6,315
| New | +$544K |
|
1235
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
| $557K | 0.01% |
+4,346
| New | +$588K |
|
1236
Stride
LRN
$3.83B
| $557K | 0.01% |
6,312
-20,205
| -76% | -$1.64M |
|
1237
Embecta
EMBC
$204M
| $556K | 0.01% |
62,887
-23,892
| -28% | -$249K |
|
1238
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.1B
| $555K | 0.01% |
11,548
-5,099
| -31% | -$256K |
|
1239
BJ's Restaurants
BJRI
$1.45B
| $552K | 0.01% |
+15,735
| New | +$629K |
|
|
CTRA
1240
DELISTED
Coterra Energy
CTRA
| $550K | 0.01% |
15,664
-35,520
| -69% | -$1.07M |
|
1241
Pitney Bowes
PBI
$2.46B
| $543K | 0.01% |
49,157
-123,013
| -71% | -$1.29M |
|
|
CNR
1242
Core Natural Resources Inc
CNR
$4.16B
| $543K | 0.01% |
5,180
+233
| +5% | +$22.2K |
|
1243
Vanguard Health Care ETF
VHT
$18.3B
| $542K | 0.01% |
+1,991
| New | +$569K |
|
1244
Dana Inc
DAN
$2.93B
| $540K | 0.01% |
16,039
-134,401
| -89% | -$4.2M |
|
1245
TORM
TRMD
$3.05B
| $540K | 0.01% |
19,340
+4,882
| +34% | +$124K |
|
1246
Alto Neuroscience
ANRO
$1.08B
| $538K | 0.01% |
+23,945
| New | +$444K |
|
1247
Douglas Dynamics
PLOW
$1.04B
| $536K | 0.01% |
12,741
-27,947
| -69% | -$1.13M |
|
1248
QCR Holdings
QCRH
$1.65B
| $533K | 0.01% |
+6,238
| New | +$543K |
|
|
CGAU
1249
Centerra Gold
CGAU
$3.27B
| $532K | 0.01% |
29,900
-48,176
| -62% | -$857K |
|
1250
Lennox International
LII
$19B
| $532K | 0.01% |
+1,146
| New | +$590K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q1 2026 Portfolio in Review
As of Q1 2026, Y-Intercept (HK) held 2,150 positions worth $5.27B, up 18% from $4.47B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.
Y-Intercept (HK) deployed $1.19B of net new capital in Q1 2026, opening 668 new positions and adding to 458 existing holdings. Its largest new stake was Micron Technology: 127,057 shares worth $42.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Charles Schwab, an estimated $32.8M trimmed.
- Y-Intercept (HK)'s largest Q1 2026 buy was Micron Technology: 127,057 shares worth $42.9M.
- Y-Intercept (HK) added most to Boston Scientific in Q1 2026, an estimated $31M increase.
- Y-Intercept (HK)'s biggest Q1 2026 reduction was Charles Schwab, cutting an estimated $32.8M.
- Y-Intercept (HK) fully exited NVIDIA in Q1 2026, selling an estimated $116M.
- Y-Intercept (HK)'s ten largest holdings make up 6.5% of its $5.27B portfolio in Q1 2026.
- Y-Intercept (HK) opened 668 new positions and closed 654 in Q1 2026.
- Y-Intercept (HK)'s portfolio value rose 18% quarter-over-quarter to $5.27B.
Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.